Skip to main content

Original Research

Clinical, Original Research
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making
Madison M. Wempe, BS, Mark D. Stewart, PhD, Daniel Glass, PhD, Laura Lasiter, PhD, Diana Merino Vega, PhD, Nisha Ramamurthy, Jeff Allen, PhD, Ellen V. Sigal, PhD
Madison M. Wempe, BS; Mark D. Stewart, PhD; Daniel Glass, PhD; Laura Lasiter, PhD; Diana Merino Vega, PhD; Nisha Ramamurthy; Jeff Allen, PhD; Ellen V. Sigal, PhD
Stakeholder Perspective
Navigating the Complex World of Diagnostic Tests and Their Role in Clinical Decision-Making
James T. Kenney, RPh, MBA
by James T. Kenney, RPh, MBA
Play Video
Clinical, Original Research
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation in a Tertiary Eye Care Center
Eileen L. Mayro, BA, Laura T. Pizzi, PharmD, MPH, Lisa A. Hark, PhD, RD, Ann P. Murchison, MD, MPH, Douglas Wisner, MD, Anish Koka, MD, Benjamin E. Leiby, PhD, Nooreen Dabbish, PhD, Adedoyin Okulate, BS, Alexa Dessy, BA, Caitlin Green, BS, Robert Bailey, MD
Eileen L. Mayro, BA; Laura T. Pizzi, PharmD, MPH; Lisa A. Hark, PhD, RD; Ann P. Murchison, MD, MPH; Douglas Wisner, MD; Anish Koka, MD; Benjamin E. Leiby, PhD; Nooreen Dabbish, PhD; Adedoyin Okulate, BS; Alexa Dessy, BA; Caitlin Green, BS; Robert Bailey, MD
Play Video
Business, Original Research
A Retrospective Cost Analysis of Patients Who Switched from OnabotulinumtoxinA to IncobotulinumtoxinA in a Private Neurology Practice
Victoria K. Karschney, David R. Greeley, MD, FAAN
Victoria K. Karschney; David R. Greeley, MD, FAAN
Play Video
Online Only
Business, Original Research
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS, Patricia R. Wigle, PharmD, Orson Austin, MD, Jeff Jianfei Guo, BPharm, PhD
Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD
Play Video
Business, Original Research
Addressing Costs and Continuity of Care through Innovative Solutions for Infused Therapies: A Collaborative Experience with Infliximab
Rhett Johnson, MA, Edward N. Freeman, FACMPE, MBA
Stakeholder Perspective
New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies
by Richard F Radzin, PharmD
Play Video
Business, Original Research
Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation
Derek Ems, MPH, Sharanya Murty, PhD, Bryan Loy, MD, Judith Gallagher, MBA, Laura E. Happe, PharmD, MPH, Teresa L. Rogstad, MPH, Debra Finnel, Jimmy D. Fernandez, MD, MBA
Derek Ems, MPH; Sharanya Murty, PhD; Bryan Loy, MD; Judith Gallagher, MBA; Laura E. Happe, PharmD, MPH; Teresa L. Rogstad, MPH; Debra Finnel; Jimmy D. Fernandez, MD, MBA
Play Video
Clinical, Original Research
Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia
Craig White, PhD, Winghan Jacqueline Kwong, PharmD, PhD, Hilary Armstrong, PhD, Michael Behling, Jeffrey Niemira, Kathy Lang, PhD
Craig White, PhD; Winghan Jacqueline Kwong, PharmD, PhD; Hilary Armstrong, PhD; Michael Behling; Jeffrey Niemira; Kathy Lang, PhD
Stakeholder Perspective
Real-World Drug Prescribing and Utilization Studies Can Inform Optimized Patient Care and Insurance Coverage
F. Randy Vogenberg, PhD, RPh
by F. Randy Vogenberg, PhD, FASHP
Play Video
Business, Original Research
Analysis of Stakeholder Engagement in the Public Comments of ICER Draft Evidence Reports
Jean A. Gerlach, Brian Snow, PharmD, Katherine M. Prioli, MS, Ronald Vertsman, PharmD, Julie Patterson, PharmD, PhD, Laura T. Pizzi, PharmD, MPH
Jean A. Gerlach; Brian Snow, PharmD; Katherine M. Prioli, MS; Ronald Vertsman, PharmD; Julie Patterson, PharmD, PhD; Laura T. Pizzi, PharmD, MPH
Play Video
Business, Original Research
Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors
Lisa M. Bloudek, PharmD, MS, Dinara Makenbaeva, MD, MBA, Michael Eaddy, PharmD, PhD
Stakeholder Perspective
Generic Imatinib: Can It Provide Significant Cost Relief for Patients?
by Gary Branning, MBA
Play Video
Clinical, Original Research
Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States
Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD, Askal A. Ali, PhD
Gilbert L. Queeley, PhD; Ellen S. Campbell, PhD; Askal A. Ali, PhD
Stakeholder Perspective
The Challenge of Maintaining Vascular Access in Patients with End-Stage Renal Disease
Raymond L. Singer, MD, MMM, CPE
by Raymond L. Singer, MD, MMM, CPE
Play Video
Page 1 of 11
Results 1 - 10 of 109